Glenmede Trust’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Glenmede Trust’s Portfolio SYNH Stock Details SYNH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-222,176	Closed	-$19.4M	–	1381
2021 Q3	$19.4M	Sell	222,176 -2,280	-1%	-$206K	0.1%	233
2021 Q2	$20.1M	Sell	224,456 -559	-0.2%	-$47.2K	0.1%	225
2021 Q1	$17.1M	Sell	225,015 -59,189	-21%	-$4.46M	0.09%	244
2020 Q4	$19.4M	Sell	284,204 -22,528	-7%	-$1.4M	0.11%	227
2020 Q3	$16.3M	Sell	306,732 -48,152	-14%	-$2.87M	0.1%	233
2020 Q2	$20.7M	Sell	354,884 -88,680	-20%	-$4.77M	0.13%	198
2020 Q1	$26.4M	Hold	443,564	–	–	0.12%	237
2019 Q4	$26.4M	Sell	443,564 -60,479	-12%	-$3.25M	0.12%	237
2019 Q3	$26.8K	Sell	504,043 -57,950	-10%	-$2.97M	0.12%	228
2019 Q2	$28.7K	Sell	561,993 -156,413	-22%	-$7.28M	0.13%	234
2019 Q1	$37.2K	Buy	718,406 +3,813	+0.5%	+$185K	0.17%	186
2018 Q4	$28.1K	Buy	+714,593	New	+$33.2M	0.14%	222
2017 Q4	–	Sell	-6,592	Closed	-$344K	–	2832
2017 Q3	$344K	Sell	6,592 -6,733	-51%	-$375K	﹤0.01%	1017
2017 Q2	$610K	Hold	13,325	–	–	﹤0.01%	893
2017 Q1	$610K	Hold	13,325	–	–	﹤0.01%	893
2016 Q4	$700K	Hold	13,325	–	–	﹤0.01%	830
2016 Q3	$594K	Hold	13,325	–	–	﹤0.01%	879
2016 Q2	$508K	Buy	13,325 +2,025	+18%	+$89K	﹤0.01%	919
2016 Q1	$465K	Buy	+11,300	New	+$466K	﹤0.01%	937

Other funds holding SYNH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Glenmede Trust's SYNH Position: Q4 2021 in Review

Glenmede Trust sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q4 2021, closing a stake of 222,176 shares — an estimated $19.4M sold.

Glenmede Trust first reported a position in SYNH in Q1 2016 and held it in 19 quarters. The position peaked at $26.4M in Q1 2020. 378 funds tracked by Wall St. Rank hold SYNH as of Q4 2021.

Glenmede Trust reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q4 2021 after selling out during the quarter.
Glenmede Trust sold 222,176 Syneos Health, Inc. Class A Common Stock shares in Q4 2021, an estimated $19.4M.
Glenmede Trust first reported a position in Syneos Health, Inc. Class A Common Stock in Q1 2016 and held it in 19 quarters.
Glenmede Trust's Syneos Health, Inc. Class A Common Stock position peaked at $26.4M in Q1 2020.
378 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q4 2021.

Based on Glenmede Trust's 13F filing for Q4 2021, filed 15 Feb 2022.